Skip to main content
. 2014 Oct 21;5(22):11054–11063. doi: 10.18632/oncotarget.2609

Table 1. Multivariate analysis according to outcome.

DFS
(HR 95% CI), p-value
CSS
(HR 95% CI), p-value
OS
(HR 95% CI), p-value
T-size* 1.76 (1.00-3.09), p=0.05 2.56 (1.24-5.28), p=0.01 1.98 (1.10-3.58), p=0.02
RN 1.84 (1.16-2.94), p=0.01 n.s. 1.83 (1.10-3.05), p=0.02
pan-hMENA 1.67 (1.00-2.81), p=0.05 2.34 (1.22-4.51), p=0.01 n.s.
hMENA11a 1.85 (1.10-3.12), p=0.02 1.88 (0.93-3.82), p=0.08 1.68 (0.97-2.91), p=0.06

DFS: disease free survival; HR: hazard ratio; CI: confidence intervals; CSS: cancer specific survival; OS: overall survival; n.s.: not significant; T-size: tumor size; RN: resected lymph nodes.

*

According to the TNM classification of malignant tumors, 7th edition.